The kids are not all right: The urgent need to expand effective behavioral health services for children and youth Vikki Wachino, Richard G. Frank, Keith Humphreys, and John O’Brien Wednesday, December 15, 2021
Comment on HHS-operated risk adjustment technical paper on possible model changes Matthew Fiedler and Timothy Layton Wednesday, December 1, 2021
Comments on Senate Finance Committee’s call for proposals to address mental health needs Richard G. Frank and Sherry Glied Wednesday, November 17, 2021
Addressing the trade-off between lower drug prices and incentives for pharmaceutical innovation Rena Conti, Richard G. Frank, and Jonathan Gruber Monday, November 15, 2021
How would filling the Medicaid “coverage gap” affect hospital finances? Matthew Fiedler Thursday, November 4, 2021
Making workplaces better for people struggling with mental health will make work better for everyone Sherry Glied and Richard G. Frank Monday, November 1, 2021
Comments on “A bold vision for America’s mental well being” Richard G. Frank and Sherry Glied Tuesday, October 19, 2021
Paying for cancer drugs that prove their benefit Richard G. Frank and Ezekiel Emanuel Thursday, October 14, 2021
From vision to design in advancing Medicare payment reform J. Michael McWilliams, Alice Chen, and Michael E. Chernew Wednesday, October 13, 2021
Amid the pandemic, Black and Latino men have experienced the largest drop in life expectancy Andre M. Perry, Ariel Gelrud Shiro, Anthony Barr, and Carl Romer Monday, October 11, 2021
The racial implications of medical debt: How moving toward universal health care and other reforms can address them Andre M. Perry, Joia Crear-Perry, Carl Romer, and Nana Adjeiwaa-Manu Tuesday, October 5, 2021
Private equity investment as a divining rod for market failure: Policy responses to harmful physician practice acquisitions Erin C. Fuse Brown, Loren Adler, Erin Duffy, Paul B. Ginsburg, Mark Hall, and Samuel Valdez Tuesday, October 5, 2021
What is the outlook for addressing social determinants of health? Stuart M. Butler Thursday, September 23, 2021
Changes in emergency physician service prices after Connecticut’s 2016 surprise billing law Loren Adler, Erin Duffy, Bich Ly, Conrad Milhaupt, and Erin Trish Thursday, September 23, 2021
Comments on No Surprises Act Rulemaking: Part I Loren Adler, Matthew Fiedler, and Benedic Ippolito Wednesday, September 1, 2021
A framework for categorizing and analyzing prescription drug pricing reform options Rachel Sachs, Loren Adler, and Paul B. Ginsburg Tuesday, August 31, 2021
Government regulated or negotiated drug prices: Key design considerations Paul B. Ginsburg and Steven M. Lieberman Monday, August 30, 2021
Comments on the development of a public health insurance option Matthew Fiedler and Loren Adler Monday, August 2, 2021
